Cite
HARVARD Citation
De La Fuente, A. et al. (n.d.). P523: MIDOSTAURIN PLUS INTENSIVE CHEMOTHERAPY IN FLT3 MUTATED AML. "REAL LIFE" DATA VERSUS THE RATIFY STUDY. HemaSphere. pp. 422-423. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
De La Fuente, A. et al. (n.d.). P523: MIDOSTAURIN PLUS INTENSIVE CHEMOTHERAPY IN FLT3 MUTATED AML. "REAL LIFE" DATA VERSUS THE RATIFY STUDY. HemaSphere. pp. 422-423. [Online].